2012Chinese Journal of AsthmaRequires access

Curative effect of thrombolysis and anticoagulant therapy on submassive pulmonary emblism patients

Wei Li, Sun Feng-chun

Open publisher page 2 citations

Abstract

Objective To observe the curative effect of thrombolysis and anticoagulant therapy on submassive pulmonary emblism (PE) patients.Methods Fifty six submassive PE patients were randomly divided thrombolysis group and anticoagulant group.The thrombolysis group were given thrombolysis therapy with Recombinant tissue plasminogen activator (rt-PA) and given anticoagulant therapy (Low molecular heparin and Warfarin) sequentially.The anticoagulant group were given anticoagulant therapy merely.The total effective rate and bleeding rate were observed.Results The total effective rate were 96.4% in thrombolysis group and higher than that in anticoagulant group (65.4%,P < 0.05).There were no intracranial hemorrhages and severe hemorrhages of other body parts.There was no significant difference in bleeding incidence rate between the two groups (P > 0.05).Conclusions If there is no contraindication of thrombolysis we should choice thrombolysis to treat submassive PE patients that can improve the symptoms of right ventricle dysfunction quickly and increase the effective treatment rate. Key words: Submassive pulmonary embolism;  Thrombolysis;  Recombinant tissue plasminogen activator

About this research paper

What this paper is about

Objective To observe the curative effect of thrombolysis and anticoagulant therapy on submassive pulmonary emblism (PE) patients.Methods Fifty six submassive PE patients were randomly divided thrombolysis group and anticoagulant group.The thrombolysis group were given thrombolysis therapy with Recombinant tissue plasminogen activator (rt-PA) and given anticoagulant therapy (Low molecular heparin and Warfarin) sequentially.The anticoagulant group were given anticoagulant therapy merely.The total effective rate and bleeding rate were observed.Results The total effective rate were 96.4% in thrombolysis group and higher than that in anticoagulant group (65.4%,P < 0.05).There were no intracranial hemorrhages and severe hemorrhages of other body parts.There was no significant difference in bleeding incidence rate between the two groups (P > 0.05).Conclusions If there is no contraindication of thrombolysis we should choice thrombolysis to treat submassive PE patients that can improve the symptoms of right ventricle dysfunction quickly and increase the effective treatment rate. Key words: Submassive pulmonary embolism;  Thrombolysis;  Recombinant tissue plasminogen activator

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the curative effect of thrombolysis and anticoagulant therapy on submassive pulmonary emblism (PE) patients.Methods Fifty six submassive PE patients were randomly divided thrombolysis group and anticoagulant group.The thrombolysis group were given thrombolysis therapy with Recombinant tissue plasminogen activator (rt-PA) and given anticoagulant therapy (Low molecular heparin and Warfarin) sequentially.The anticoagulant group were given anticoagulant therapy merely.The total effective rate and bleeding rate were observed.Results The total effective rate were 96.4% in thrombolysis group and higher than that in anticoagulant group (65.4%,P < 0.05).There were no intracranial hemorrhages and severe hemorrhages of other body parts.There was no significant difference in bleeding incidence rate between the two groups (P > 0.05).Conclusions If there is no contraindication of thrombolysis we should choice thrombolysis to treat submassive PE patients that can improve the symptoms of right ventricle dysfunction quickly and increase the effective treatment rate. Key words: Submassive pulmonary embolism;  Thrombolysis;  Recombinant tissue plasminogen activator

Key concepts: Thrombolysis, Medicine, Pulmonary embolism, Contraindication, Anticoagulant therapy, Warfarin, Internal medicine, Anticoagulant

Related papers

Back to paper searchBrowse research topicsOriginal source
Curative effect of thrombolysis and anticoagulant therapy on submassive pulmonary emblism patients — Research Paper | ScholarLens